Symbols / BFRI $0.98 -0.09% Biofrontera Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NCM
BFRI Chart
About

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Drug Manufacturers - Spe Market Cap 11.40M
Enterprise Value 11.17M Income -10.54M Sales 41.70M
Book/sh 0.90 Cash/sh 0.55 Dividend Yield —
Payout 0.00% Employees 84 IPO —
P/E — Forward P/E -4.26 PEG —
P/S 0.27 P/B 1.09 P/C —
EV/EBITDA -1.00 EV/Sales 0.27 Quick Ratio 1.31
Current Ratio 1.52 Debt/Eq 58.79 LT Debt/Eq —
EPS (ttm) -1.04 EPS next Y -0.23 EPS Growth —
Revenue Growth 36.20% Earnings 2026-05-14 ROA -28.00%
ROE -141.30% ROIC — Gross Margin 73.71%
Oper. Margin 26.66% Profit Margin -25.26% Shs Outstand 11.65M
Shs Float 7.95M Short Float 1.53% Short Ratio 1.14
Short Interest — 52W High 1.19 52W Low 0.54
Beta 0.64 Avg Volume 381.76K Volume 46.72K
Target Price $6.00 Recom None Prev Close $0.98
Price $0.98 Change -0.09%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.00
Mean price target
2. Current target
$0.99
Latest analyst target
3. DCF / Fair value
$-3.65
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.99
Low
$3.00
High
$9.00
Mean
$6.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-05-19 main Benchmark Buy → Buy $3
2024-11-15 reit Benchmark Buy → Buy $7
2024-08-16 reit Benchmark Buy → Buy $7
2023-08-31 reit Benchmark Buy → Buy $18
News
RSS: Latest BFRI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-05 LUEBBERT HERMANN Chief Executive Officer — 137,500 — —
2026-03-05 LEFFLER EUGENE FREDERICK Chief Financial Officer — 87,500 — —
2025-09-10 LUEBBERT HERMANN Chief Executive Officer — 137,500 — —
2025-09-10 LEFFLER EUGENE FREDERICK Chief Financial Officer — 87,500 — —
2024-05-17 LUEBBERT HERMANN Chief Executive Officer — 4,771 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
41.70
+11.75%
37.32
+9.54%
34.07
+18.82%
28.67
Operating Revenue
41.70
+11.75%
37.32
+9.54%
34.07
+18.82%
28.67
Cost Of Revenue
10.96
-41.08%
18.61
+6.67%
17.44
+14.88%
15.19
Reconciled Cost Of Revenue
10.96
-41.08%
18.61
+6.67%
17.44
+14.88%
15.19
Gross Profit
30.74
+64.27%
18.71
+12.55%
16.63
+23.26%
13.49
Operating Expense
42.09
+17.16%
35.92
-8.37%
39.20
+9.29%
35.87
Research And Development
3.72
+78.03%
2.09
+2612.99%
0.08
0.00
Selling General And Administration
38.37
+13.40%
33.84
-13.53%
39.13
+9.08%
35.87
General And Administrative Expense
—
—
39.13
+9.08%
35.87
Other Gand A
—
—
39.13
+9.08%
35.87
Total Expenses
53.05
-2.71%
54.53
-3.74%
56.65
+10.95%
51.05
Operating Income
-11.35
+34.06%
-17.21
+23.77%
-22.58
-0.88%
-22.38
Total Operating Income As Reported
-11.35
+34.06%
-17.21
+24.11%
-22.68
-22.04%
-18.58
EBITDA
-9.19
+36.84%
-14.55
+21.13%
-18.45
-2075.70%
0.93
Normalized EBITDA
-10.09
+36.54%
-15.90
+25.95%
-21.48
-2.40%
-20.97
Reconciled Depreciation
0.87
-24.46%
1.15
+7.99%
1.06
-9.22%
1.17
EBIT
-10.06
+35.94%
-15.70
+19.55%
-19.52
-8100.42%
-0.24
Total Unusual Items
0.90
-33.26%
1.35
-55.34%
3.02
-86.20%
21.91
Total Unusual Items Excluding Goodwill
0.90
-33.26%
1.35
-55.34%
3.02
-86.20%
21.91
Special Income Charges
0.00
+100.00%
-0.32
-104.26%
7.42
+95.24%
3.80
Other Special Charges
—
0.32
+104.20%
-7.52
—
Restructuring And Mergern Acquisition
—
0.00
-100.00%
0.10
+102.63%
-3.80
Net Income
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Pretax Income
-10.51
+40.74%
-17.74
+11.83%
-20.12
-3208.72%
-0.61
Net Non Operating Interest Income Expense
-0.45
+77.79%
-2.04
-263.39%
-0.56
-175.86%
-0.20
Interest Expense Non Operating
0.45
-77.79%
2.04
+239.17%
0.60
+62.16%
0.37
Net Interest Income
-0.45
+77.79%
-2.04
-263.39%
-0.56
-175.86%
-0.20
Interest Expense
0.45
-77.79%
2.04
+239.17%
0.60
+62.16%
0.37
Interest Income Non Operating
—
0.07
-46.21%
0.13
-24.57%
0.17
Interest Income
—
0.07
-46.21%
0.13
-24.57%
0.17
Other Income Expense
1.29
-14.52%
1.51
-50.07%
3.02
-86.26%
21.98
Other Non Operating Income Expenses
0.39
+145.57%
0.16
+5366.67%
-0.00
-104.35%
0.07
Gain On Sale Of Security
0.90
-45.92%
1.67
+137.90%
-4.40
-124.28%
18.11
Tax Provision
0.03
+13.64%
0.02
+57.14%
0.01
-56.25%
0.03
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.19
-33.26%
0.28
-55.34%
0.63
-86.20%
4.60
Net Income Including Noncontrolling Interests
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Net Income From Continuing Operation Net Minority Interest
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Net Income From Continuing And Discontinued Operation
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Net Income Continuous Operations
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Normalized Income
-11.25
+40.25%
-18.83
+16.40%
-22.52
-25.48%
-17.95
Net Income Common Stockholders
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Diluted EPS
—
-3.22
+75.27%
-13.02
-2615.79%
-0.48
Basic EPS
—
-3.22
+75.27%
-13.02
-2615.79%
-0.48
Basic Average Shares
—
5.52
+256.74%
1.55
+15.83%
1.33
Diluted Average Shares
—
5.52
+256.74%
1.55
+15.83%
1.33
Diluted NI Availto Com Stockholders
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Total Other Finance Cost
—
0.04
-55.43%
0.09
+1050.00%
0.01
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
28.56
+29.24%
22.10
-20.88%
27.93
-45.11%
50.88
Current Assets
18.08
-12.64%
20.70
-10.29%
23.07
-46.51%
43.14
Cash Cash Equivalents And Short Term Investments
6.40
+8.27%
5.91
+316.05%
1.42
-94.88%
27.76
Cash And Cash Equivalents
6.39
+8.25%
5.91
+339.69%
1.34
-92.20%
17.21
Other Short Term Investments
0.01
+28.57%
0.01
-91.03%
0.08
-99.26%
10.55
Receivables
8.51
+58.40%
5.37
+4.07%
5.16
-30.30%
7.41
Accounts Receivable
7.29
+37.18%
5.32
+2.96%
5.16
+37.73%
3.75
Gross Accounts Receivable
7.39
+34.02%
5.51
+2.85%
5.36
+39.35%
3.85
Allowance For Doubtful Accounts Receivable
-0.10
+50.00%
-0.20
+0.00%
-0.20
-100.00%
-0.10
Other Receivables
—
—
—
—
Taxes Receivable
1.22
+2036.84%
0.06
—
—
Inventory
1.43
-78.54%
6.65
-39.07%
10.91
+52.18%
7.17
Prepaid Assets
0.55
+144.05%
0.23
-25.57%
0.30
-41.79%
0.52
Assets Held For Sale Current
0.00
-100.00%
2.30
0.00
—
Other Current Assets
1.19
+390.95%
0.24
-95.65%
5.58
+1852.45%
0.29
Total Non Current Assets
10.48
+648.11%
1.40
-71.16%
4.86
-37.28%
7.74
Net PPE
3.74
+280.67%
0.98
-43.70%
1.75
+10.58%
1.58
Gross PPE
4.01
+151.19%
1.60
-8.59%
1.75
-16.30%
2.09
Accumulated Depreciation
-0.27
+56.44%
-0.61
-10.05%
-0.56
-9.86%
-0.51
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
2.42
+646.15%
0.33
+0.62%
0.32
-5.83%
0.34
Other Properties
1.58
+75.42%
0.90
-48.28%
1.75
+26.98%
1.38
Leases
0.00
-100.00%
0.37
+0.00%
0.37
+0.00%
0.37
Goodwill And Other Intangible Assets
2.65
+7471.43%
0.04
-98.67%
2.63
-13.29%
3.03
Other Intangible Assets
2.65
+7471.43%
0.04
-98.67%
2.63
-13.29%
3.03
Non Current Accounts Receivable
—
—
—
2.81
Other Non Current Assets
4.09
+967.62%
0.38
-20.54%
0.48
+50.63%
0.32
Total Liabilities Net Minority Interest
18.08
+2.35%
17.67
-23.64%
23.14
-14.32%
27.01
Current Liabilities
11.89
-1.05%
12.02
-33.54%
18.09
-13.43%
20.89
Payables And Accrued Expenses
8.38
+0.08%
8.37
-20.04%
10.47
+3.18%
10.15
Payables
6.67
-7.42%
7.20
-20.05%
9.01
+247.72%
2.59
Accounts Payable
1.85
-0.05%
1.86
-43.89%
3.31
+158.84%
1.28
Current Accrued Expenses
1.72
+46.08%
1.17
-19.97%
1.47
-80.60%
7.56
Pensionand Other Post Retirement Benefit Plans Current
2.81
+15.53%
2.43
+11.12%
2.19
-23.33%
2.85
Current Debt And Capital Lease Obligation
0.33
-39.42%
0.55
-88.07%
4.59
+822.69%
0.50
Current Debt
—
—
3.90
—
Other Current Borrowings
—
—
3.90
—
Current Capital Lease Obligation
0.33
-39.42%
0.55
-20.69%
0.69
+38.76%
0.50
Current Deferred Liabilities
—
—
0.00
-100.00%
6.94
Current Deferred Revenue
—
—
0.00
-100.00%
6.94
Other Current Liabilities
0.32
-47.80%
0.61
-10.64%
0.69
+84.41%
0.37
Total Non Current Liabilities Net Minority Interest
6.19
+9.60%
5.65
+11.80%
5.05
-17.36%
6.11
Long Term Debt And Capital Lease Obligation
5.83
+33.26%
4.37
+444.03%
0.80
-5.19%
0.85
Long Term Debt
4.59
+11.98%
4.10
—
—
Long Term Capital Lease Obligation
1.24
+349.28%
0.28
-65.67%
0.80
-5.19%
0.85
Non Current Deferred Liabilities
—
—
0.00
-100.00%
2.40
Non Current Deferred Revenue
—
—
0.00
-100.00%
2.40
Other Non Current Liabilities
0.01
-60.87%
0.02
-37.84%
0.04
+76.19%
0.02
Stockholders Equity
10.48
+136.41%
4.43
-7.51%
4.79
-79.93%
23.88
Common Stock Equity
10.48
+136.41%
4.43
-7.51%
4.79
-79.93%
23.88
Capital Stock
0.01
+33.33%
0.01
+350.00%
0.00
+100.00%
0.00
Common Stock
0.01
+33.33%
0.01
+350.00%
0.00
+100.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
11.65
+31.26%
8.87
+484.72%
1.52
+13.68%
1.33
Ordinary Shares Number
11.65
+31.26%
8.87
+484.72%
1.52
+13.68%
1.33
Additional Paid In Capital
138.41
+13.61%
121.83
+16.65%
104.44
+1.01%
103.40
Retained Earnings
-127.94
-8.97%
-117.41
-17.82%
-99.65
-25.32%
-79.52
Total Equity Gross Minority Interest
10.48
+136.41%
4.43
-7.51%
4.79
-79.93%
23.88
Total Capitalization
15.07
+76.64%
8.53
+77.99%
4.79
-79.93%
23.88
Working Capital
6.19
-28.70%
8.68
+74.03%
4.99
-77.58%
22.25
Invested Capital
15.07
+76.64%
8.53
-1.91%
8.70
-63.58%
23.88
Total Debt
6.16
+25.17%
4.92
-8.83%
5.40
+301.11%
1.35
Net Debt
—
—
2.56
—
Capital Lease Obligations
1.57
+90.78%
0.82
-44.88%
1.50
+11.07%
1.35
Net Tangible Assets
7.83
+78.04%
4.40
+103.23%
2.16
-89.62%
20.85
Tangible Book Value
7.83
+78.04%
4.40
+103.23%
2.16
-89.62%
20.85
Current Provisions
0.06
-1.72%
0.06
-61.07%
0.15
+81.71%
0.08
Derivative Product Liabilities
0.35
-71.92%
1.25
-70.31%
4.21
+48.08%
2.84
Duefrom Related Parties Current
—
—
0.00
-100.00%
3.66
Duefrom Related Parties Non Current
—
—
0.00
-100.00%
2.81
Dueto Related Parties Current
4.81
-9.97%
5.34
-6.21%
5.70
+334.30%
1.31
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-13.36
-30.10%
-10.27
+58.75%
-24.89
-53.68%
-16.20
Cash Flow From Continuing Operating Activities
-13.36
-30.10%
-10.27
+58.75%
-24.89
-53.68%
-16.20
Net Income From Continuing Operations
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Depreciation Amortization Depletion
0.87
-24.46%
1.15
+7.99%
1.06
-9.22%
1.17
Depreciation
0.87
-24.46%
1.15
+77.86%
0.65
-14.32%
0.75
Amortization Cash Flow
—
0.33
-21.29%
0.42
+0.00%
0.42
Depreciation And Amortization
0.87
-24.46%
1.15
+7.99%
1.06
-9.22%
1.17
Amortization Of Intangibles
—
0.33
-21.29%
0.42
+0.00%
0.42
Other Non Cash Items
0.51
+71.72%
0.30
+104.31%
-6.88
-99.97%
-3.44
Stock Based Compensation
0.95
-6.67%
1.02
-2.49%
1.04
-43.57%
1.85
Provisionand Write Offof Assets
-0.07
-142.59%
0.16
+32.79%
0.12
-40.78%
0.21
Operating Gains Losses
-1.60
-18.59%
-1.35
-131.53%
4.28
+126.13%
-16.39
Gain Loss On Investment Securities
-0.90
+45.92%
-1.67
-138.91%
4.28
+126.13%
-16.39
Unrealized Gain Loss On Investment Securities
—
—
7.42
+524.79%
-1.75
Gain Loss On Sale Of PPE
-0.70
0.00
—
—
Change In Working Capital
-3.48
-156.08%
6.21
+241.37%
-4.39
-257.60%
2.79
Change In Receivables
-1.91
-509.27%
-0.31
-106.34%
4.93
+0.28%
4.92
Changes In Account Receivables
-1.91
-505.40%
-0.32
+79.49%
-1.54
-2094.29%
-0.07
Change In Inventory
1.45
-65.86%
4.23
+212.88%
-3.75
-33.45%
-2.81
Change In Prepaid Assets
-1.73
-1125.53%
-0.14
-181.03%
0.17
-95.81%
4.15
Change In Payables And Accrued Expense
0.07
+103.68%
-2.04
-3282.81%
0.06
+102.37%
-2.69
Change In Accrued Expense
0.61
+365.22%
-0.23
+96.38%
-6.35
-76.07%
-3.61
Change In Payable
-0.54
+70.39%
-1.81
-128.17%
6.42
+603.40%
0.91
Change In Account Payable
-0.54
+70.39%
-1.81
-128.17%
6.42
—
Change In Other Current Assets
-0.69
-113.30%
5.16
+200.00%
-5.16
0.00
Change In Other Current Liabilities
-0.68
+0.87%
-0.69
-4.87%
-0.66
+15.88%
-0.78
Investing Cash Flow
3.00
+100033.33%
-0.00
-100.48%
0.62
+112.01%
-5.16
Cash Flow From Continuing Investing Activities
3.00
+100033.33%
-0.00
-100.48%
0.62
+112.01%
-5.16
Net PPE Purchase And Sale
-0.00
+80.00%
-0.01
-100.00%
-0.01
+86.84%
-0.04
Purchase Of PPE
-0.00
+80.00%
-0.01
-100.00%
-0.01
+86.84%
-0.04
Capital Expenditure
-0.00
+96.67%
-0.06
-1100.00%
-0.01
+86.84%
-0.04
Net Investment Purchase And Sale
0.00
-100.00%
0.06
-90.87%
0.62
+112.19%
-5.12
Purchase Of Investment
—
—
0.00
+100.00%
-5.12
Sale Of Investment
0.00
-100.00%
0.06
-90.87%
0.62
0.00
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.05
0.00
—
Purchase Of Intangibles
0.00
+100.00%
-0.05
0.00
—
Net Other Investing Changes
3.00
—
—
—
Financing Cash Flow
10.85
-26.86%
14.84
+76.38%
8.41
-40.01%
14.02
Cash Flow From Continuing Financing Activities
10.85
-26.86%
14.84
+76.38%
8.41
-40.01%
14.02
Net Issuance Payments Of Debt
0.00
+100.00%
-0.27
-106.79%
3.90
0.00
Issuance Of Debt
—
4.05
-83.96%
25.25
0.00
Repayment Of Debt
0.00
+100.00%
-4.32
+79.78%
-21.34
—
Long Term Debt Issuance
—
—
21.45
0.00
Net Long Term Debt Issuance
—
—
21.45
0.00
Short Term Debt Issuance
—
4.05
-83.96%
25.25
0.00
Short Term Debt Payments
0.00
+100.00%
-4.32
+79.78%
-21.34
—
Net Short Term Debt Issuance
0.00
+100.00%
-0.27
-106.79%
3.90
0.00
Net Common Stock Issuance
—
0.00
-100.00%
4.51
-52.01%
9.39
Proceeds From Stock Option Exercised
0.00
-100.00%
7.44
0.00
-100.00%
4.63
Changes In Cash
0.49
-89.32%
4.56
+128.76%
-15.87
-116.32%
-7.33
Beginning Cash Position
6.11
+295.66%
1.54
-91.14%
17.41
-29.64%
24.74
End Cash Position
6.59
+7.98%
6.11
+295.66%
1.54
-91.14%
17.41
Free Cash Flow
-13.36
-29.36%
-10.33
+58.51%
-24.90
-53.35%
-16.24
Interest Paid Supplemental Data
0.01
-99.65%
1.73
+1075.51%
0.15
+14600.00%
0.00
Income Tax Paid Supplemental Data
0.03
+4.17%
0.02
+60.00%
0.01
-53.13%
0.03
Common Stock Issuance
—
0.00
-100.00%
4.51
-52.01%
9.39
Issuance Of Capital Stock
10.85
+41.61%
7.66
+70.00%
4.51
-52.01%
9.39
Net Preferred Stock Issuance
10.85
+41.61%
7.66
0.00
—
Preferred Stock Issuance
10.85
+41.61%
7.66
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category